News Forget the doctor, why not just ask ChatGPT? In a study of random patient questions drawn from the Reddit social media platform, people responded more positively to answers provided by
News BenevolentAI lead atopic dermatitis drug misses the mark BenevolentAI has reported disappointing results in a phase 2 trial of lead drug BEN-2293 in atopic dermatitis (AD), as the drug was unable to show the hoped-for effect on
News Poll finds just one fifth of doctors have prescribed a DTx A large, international survey of thousands of doctors has revealed that a majority are still not confident enough to prescribe
News Japanese pharmas sign up to use new AI supercomputer Mitsui, NVIDIA's Tokyo-1 supercomputer, aims to turbocharge Japan’s use of AI in drug discovery
Digital AI technology: A game-changer for rare disease diagnosis AI technology isn’t designed to replace clinicians - its function is to help them.
News Exscientia builds cancer pipeline with two BMS drugs LSD1 and MALT1 inhibitors inherited from BMS alliance will be biotech's next cancer candidates.
News UK digital health funding should be ringfenced, says report IT industry group techUK has called on the government to guarantee funding for digital transformation and cyber resilience in health and social care
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends